BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 12209352)

  • 1. Early infections in adults undergoing matched related and matched unrelated/mismatched donor stem cell transplantation: a comparison of incidence.
    van Kraaij MG; Verdonck LF; Rozenberg-Arska M; Dekker AW
    Bone Marrow Transplant; 2002 Sep; 30(5):303-9. PubMed ID: 12209352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of Viral and fungal infections following busulfan-based reduced-intensity versus myeloablative conditioning in pediatric allogeneic stem cell transplantation recipients.
    Satwani P; Baldinger L; Freedman J; Jacobson JS; Guerra J; van de Ven C; Morris E; Garvin J; George D; Bradley MB; Bhatia M; Tallamy B; Schwartz J; Jin Z; Cairo MS
    Biol Blood Marrow Transplant; 2009 Dec; 15(12):1587-95. PubMed ID: 19896083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infectious complications after allogeneic stem cell transplantation: incidence in matched-related and matched-unrelated transplant settings.
    Rieger CT; Rieger H; Kolb HJ; Peterson L; Huppmann S; Fiegl M; Ostermann H
    Transpl Infect Dis; 2009 Jun; 11(3):220-6. PubMed ID: 19298239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoroquinolone resistance in hematopoietic stem cell transplant recipients with infectious complications.
    Bonadio M; Morelli G; Mori S; Riccioni R; Papineschi F; Petrini M
    Biomed Pharmacother; 2005 Oct; 59(9):511-6. PubMed ID: 16274955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-year survival rates for all consecutive heart-only and lung-only transplants performed in Eurotransplant, 1997-1999.
    Smits JM; Vanhaecke J; Haverich A; de Vries E; Smith M; Rutgrink E; Ramsoebhag A; Hop A; Persijn G; Laufer G
    Clin Transpl; 2003; ():89-100. PubMed ID: 15387100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of postengraftment infectious morbidity and mortality after allogeneic partially T cell-depleted peripheral blood progenitor cell transplantation versus T cell-depleted bone marrow transplantation.
    Broers AE; van der Holt B; Haze S; Braakman E; Gratama JW; Löwenberg B; Cornelissen JJ
    Exp Hematol; 2005 Aug; 33(8):912-9. PubMed ID: 16038784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenoviral infection after allogeneic stem cell transplantation (SCT): report on 130 patients from a single SCT unit involved in a prospective multi center surveillance study.
    Runde V; Ross S; Trenschel R; Lagemann E; Basu O; Renzing-Köhler K; Schaefer UW; Roggendorf M; Holler E
    Bone Marrow Transplant; 2001 Jul; 28(1):51-7. PubMed ID: 11498744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycobacterial infection: a difficult and late diagnosis in stem cell transplant recipients.
    Cordonnier C; Martino R; Trabasso P; Held TK; Akan H; Ward MS; Fabian K; Ullmann AJ; Wulffraat N; Ljungman P; Alessandrino EP; Pretnar J; Gmür J; Varela R; Vitek A; Sica S; Rovira M;
    Clin Infect Dis; 2004 May; 38(9):1229-36. PubMed ID: 15127333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infections in non-myeloablative hematopoietic stem cell transplantation patients with lymphoid malignancies: spectrum of infections, predictors of outcome and proposed guidelines for fungal infection prevention.
    Safdar A; Rodriguez GH; Mihu CN; Mora-Ramos L; Mulanovich V; Chemaly RF; Champlin RE; Khouri I
    Bone Marrow Transplant; 2010 Feb; 45(2):339-47. PubMed ID: 19561648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone marrow transplantation.
    Parody R; Martino R; Rovira M; Vazquez L; Vázquez MJ; de la Cámara R; Blazquez C; Fernández-Avilés F; Carreras E; Salavert M; Jarque I; Martín C; Martínez F; López J; Torres A; Sierra J; Sanz GF;
    Biol Blood Marrow Transplant; 2006 Jul; 12(7):734-48. PubMed ID: 16785063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients.
    Mikulska M; Raiola AM; Bruno B; Furfaro E; Van Lint MT; Bregante S; Ibatici A; Del Bono V; Bacigalupo A; Viscoli C
    Bone Marrow Transplant; 2009 Sep; 44(6):361-70. PubMed ID: 19308042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infectious complications associated with renal transplantation: an analysis of risk factors.
    Ahern MJ; Comite H; Andriole VT
    Yale J Biol Med; 1978; 51(5):513-25. PubMed ID: 373266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Listeriosis in recipients of allogeneic blood and marrow transplantation: thirteen year review of disease characteristics, treatment outcomes and a new association with human cytomegalovirus infection.
    Safdar A; Papadopoulous EB; Armstrong D
    Bone Marrow Transplant; 2002 Jun; 29(11):913-6. PubMed ID: 12080357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenoviral infections after transplantation of positive selected stem cells from haploidentical donors in children: an update.
    Feuchtinger T; Richard C; Pfeiffer M; Neuhäuser F; Lücke J; Handgretinger R; Greil J; Bader P; Klingebiel T; Schlegel PG; Jahn G; Niethammer D; Lang P
    Klin Padiatr; 2005; 217(6):339-44. PubMed ID: 16307420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies.
    Ozdemir E; Saliba RM; Champlin RE; Couriel DR; Giralt SA; de Lima M; Khouri IF; Hosing C; Kornblau SM; Anderlini P; Shpall EJ; Qazilbash MH; Molldrem JJ; Chemaly RF; Komanduri KV
    Bone Marrow Transplant; 2007 Jul; 40(2):125-36. PubMed ID: 17530009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of bacteremias and invasive mycoses in children undergoing allogeneic hematopoietic stem cell transplantation: a single center experience.
    Castagnola E; Bagnasco F; Faraci M; Caviglia I; Caruso S; Cappelli B; Moroni C; Morreale G; Timitilli A; Tripodi G; Lanino E; Haupt R
    Bone Marrow Transplant; 2008 Feb; 41(4):339-47. PubMed ID: 18026151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fusarium infection in hematopoietic stem cell transplant recipients.
    Nucci M; Marr KA; Queiroz-Telles F; Martins CA; Trabasso P; Costa S; Voltarelli JC; Colombo AL; Imhof A; Pasquini R; Maiolino A; Souza CA; Anaissie E
    Clin Infect Dis; 2004 May; 38(9):1237-42. PubMed ID: 15127334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for late infections after allogeneic hematopoietic stem cell transplantation from a matched related donor.
    Robin M; Porcher R; De Castro Araujo R; de Latour RP; Devergie A; Rocha V; Larghero J; Adès L; Ribaud P; Mary JY; Socié G
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1304-12. PubMed ID: 17950917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for late cytomegalovirus infection after allogeneic stem cell transplantation using HLA-matched sibling donor: donor lymphocyte infusion and previous history of early CMV infection.
    Kim DH; Kim JG; Lee NY; Sung WJ; Sohn SK; Suh JS; Lee KS; Lee KB
    Bone Marrow Transplant; 2004 Jul; 34(1):21-7. PubMed ID: 15133483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-transplant infections: single center experience from the developing world.
    Ullah K; Raza S; Ahmed P; Chaudhry QU; Satti TM; Ahmed S; Mirza SH; Akhtar F; Kamal K; Akhtar FM
    Int J Infect Dis; 2008 Mar; 12(2):203-14. PubMed ID: 17920999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.